Haji Glover
Vermögen: 1 Mio $ am 31.07.2026
Vermögen: 1 Mio $ am 31.07.2026
Haji L.
Glover is Chief Financial Officer & Executive Vice President at Scholastic Corp.
since 2024.
Formerly, served as Finance Director at Amazon.com, Inc. from 2022 to 2024, Senior Vice President-Corporate Finance at Scholastic Corp.
from 2020 to 2022, and VP-Global Financial Reporting & Analysis at Alvogen, Inc. from 2012 to 2020.
Education includes undergraduate studies at Lehigh University and an MBA from State University of New York at Binghamton.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.01.2026 | 25’322 ( 0.14% ) | 1 Mio $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SCHOLASTIC CORPORATION | Finanzdirektor/CFO | 22.01.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
| AMAZON.COM, INC. | Finanzdirektor/CFO | 01.01.2024 |
| SCHOLASTIC CORPORATION | Finanzdirektor/CFO | 01.01.2022 |
Alvogen, Inc.
Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Corporate Officer/Principal | 01.01.2020 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Scholastic Corp.
Scholastic Corp. Publishing: Books/MagazinesConsumer Services Publishes and distributes books, magazines, teacher materials and television programming for children | Consumer Services |
Amazon.com, Inc.
Amazon.com, Inc. Internet RetailRetail Trade Provides online retail shopping services | Retail Trade |
Lehigh University
Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Binghamton
State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alvogen, Inc.
Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen